CGON
CG ONCOLOGY (CGON)
NASDAQ
$65.87+$0.13 (+0.21%)
Price as of Jun 23, 2026 5:01 PM EDT
  • $5.8B
    Market Cap
  • 158.18%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
3.2M
+183.93%
1.1M
N/A
Cost of Revenue
194.8M
N/A
N/A
N/A
Gross Profit
-191.6M
-16,920.02%
1.1M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-116.6M
+42.07%
-82.1M
N/A
Depreciation and Amortization Expense
1.4M
+4,415.63%
32,000
N/A
Total Operating Expenses
268.3M
+131.72%
115.8M
N/A
Operating Profit
-190.8M
+66.37%
-114.7M
N/A
Interest Income
29.9M
+12.42%
26.6M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
29.9M
+12.42%
26.6M
N/A
Total Nonoperating Income and Expense
29.8M
+11.84%
26.6M
N/A
Income before Taxes
-161.0M
+82.87%
-88.0M
N/A
Income Taxes
-270,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-161.0M
+82.87%
-88.0M
N/A
Net Income from Continuing Operations Applicable to Common
-161.0M
+82.87%
-88.0M
N/A
Basic EPS and Net Income
-2.08
+47.52%
-1.41
N/A
Diluted EPS and Net Income
-2.08
+47.52%
-1.41
N/A
Basic Weighted Average Shares
77.3M
+23.69%
62.5M
N/A
Diluted Weighted Average Shares
77.3M
+23.69%
62.5M
N/A
Balance Sheet
Cash and Cash Equivalents
32.5M
-87.36%
257.1M
N/A
Short-Term Investments
709.7M
+46.34%
484.9M
N/A
Cash and Cash Equivalents and Short-Term Investments
742.2M
+0.02%
742.0M
N/A
Total Current Assets
759.5M
+0.70%
754.2M
N/A
Accumulated Depreciation
1.5M
N/A
N/A
N/A
Property and Plant and Equipment and Net
15.6M
+5,633.82%
272,000
N/A
Total Long-Term Assets
1.7M
+1,685.11%
94,000
N/A
Total Assets
791.6M
+4.87%
754.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
30.8M
+44.31%
21.4M
N/A
Total Long-Term Debt
3.0M
N/A
N/A
N/A
Total Long-Term Liabilities
1.7M
+3,248.08%
52,000
N/A
Total Liabilities
39.0M
+82.03%
21.4M
N/A
Retained Earnings
-379.0M
+73.86%
-218.0M
N/A
Total Stockholders Equity
752.6M
+2.62%
733.4M
N/A
Total Shares Outstanding
80.7M
+5.95%
76.2M
N/A
Cash Flow
Cash from Operating Activities
-132.3M
+68.14%
-78.7M
N/A
Capital Expenditures
134,000
-42.74%
234,000
N/A
Cash from Investing Activities
-245.8M
-18.27%
-300.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
153.6M
-75.55%
628.3M
N/A
Financials Ratio
Gross Margin
-5,923.93%
N/A
N/A
N/A
Operating Margin
-5,899.01%
N/A
N/A
N/A
Return on Assets
-20.82%
N/A
N/A
N/A
Return on Equity
-21.67%
N/A
N/A
N/A
Revenue Growth
183.93%
N/A
N/A
N/A
Current Ratio
24.63
N/A
N/A
N/A
Cash Ratio
1.05
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow